Viridien
Short position disclosed on October 21, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| December 1, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 | |
| November 30, 2023 | Qube Research & Technologies Limited | 1.17% | March 4, 2024 | |
| November 29, 2023 | Qube Research & Technologies Limited | 1.26% | March 4, 2024 | |
| November 28, 2023 | Qube Research & Technologies Limited | 1.31% | March 4, 2024 | |
| November 24, 2023 | Qube Research & Technologies Limited | 1.25% | March 4, 2024 | |
| November 22, 2023 | Marshall Wace LLP | 2.08% | March 24, 2025 | |
| November 22, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 | |
| November 21, 2023 | Qube Research & Technologies Limited | 1.17% | March 4, 2024 | |
| November 20, 2023 | Qube Research & Technologies Limited | 1.02% | March 4, 2024 | |
| November 17, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 | |
| November 16, 2023 | Marshall Wace LLP | 2.13% | March 24, 2025 | |
| November 16, 2023 | Qube Research & Technologies Limited | 1.20% | March 4, 2024 | |
| November 15, 2023 | Qube Research & Technologies Limited | 1.05% | March 4, 2024 | |
| November 14, 2023 | Marshall Wace LLP | 2.05% | March 24, 2025 | |
| November 14, 2023 | Qube Research & Technologies Limited | 1.11% | March 4, 2024 | |
| November 14, 2023 | ActusRayPartners Limited | 0.47% | November 16, 2023 | |
| November 13, 2023 | Qube Research & Technologies Limited | 1.27% | March 4, 2024 | |
| November 9, 2023 | Qube Research & Technologies Limited | 1.19% | March 4, 2024 | |
| November 7, 2023 | Qube Research & Technologies Limited | 1.28% | March 4, 2024 | |
| November 7, 2023 | POINT72 Asset Management, L.P. | 0.49% | November 9, 2023 | AMF |
| November 6, 2023 | Marshall Wace LLP | 2.12% | March 24, 2025 | |
| November 6, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 | |
| November 3, 2023 | Marshall Wace LLP | 2.02% | March 24, 2025 | |
| November 3, 2023 | Qube Research & Technologies Limited | 1.29% | March 4, 2024 | |
| November 2, 2023 | Marshall Wace LLP | 1.94% | March 24, 2025 | |
| November 1, 2023 | Qube Research & Technologies Limited | 1.46% | March 4, 2024 | |
| October 31, 2023 | POINT72 Asset Management, L.P. | 0.59% | November 9, 2023 | AMF |
| October 30, 2023 | Marshall Wace LLP | 1.82% | March 24, 2025 | |
| October 30, 2023 | Qube Research & Technologies Limited | 1.56% | March 4, 2024 | |
| October 27, 2023 | Marshall Wace LLP | 1.76% | March 24, 2025 | |
| October 27, 2023 | Qube Research & Technologies Limited | 1.62% | March 4, 2024 | |
| October 26, 2023 | Qube Research & Technologies Limited | 1.72% | March 4, 2024 | |
| October 25, 2023 | Marshall Wace LLP | 1.62% | March 24, 2025 | |
| October 24, 2023 | Marshall Wace LLP | 1.53% | March 24, 2025 | |
| October 23, 2023 | Qube Research & Technologies Limited | 1.81% | March 4, 2024 | |
| October 23, 2023 | Marshall Wace LLP | 1.44% | March 24, 2025 | |
| October 20, 2023 | Marshall Wace LLP | 1.34% | March 24, 2025 | |
| October 20, 2023 | POINT72 Asset Management, L.P. | 0.69% | November 9, 2023 | AMF |
| October 19, 2023 | ActusRayPartners Limited | 0.50% | November 16, 2023 | |
| October 18, 2023 | Qube Research & Technologies Limited | 1.75% | March 4, 2024 | |
| October 17, 2023 | Marshall Wace LLP | 1.22% | March 24, 2025 | |
| October 17, 2023 | ActusRayPartners Limited | 0.47% | October 19, 2023 | |
| October 16, 2023 | Qube Research & Technologies Limited | 1.88% | March 4, 2024 | |
| October 13, 2023 | Marshall Wace LLP | 1.13% | March 24, 2025 | |
| October 12, 2023 | Qube Research & Technologies Limited | 1.97% | March 4, 2024 | |
| October 12, 2023 | ActusRayPartners Limited | 0.51% | October 19, 2023 | |
| October 11, 2023 | POINT72 Asset Management, L.P. | 0.78% | November 9, 2023 | AMF |
| October 10, 2023 | Qube Research & Technologies Limited | 2.01% | March 4, 2024 | |
| October 6, 2023 | Marshall Wace LLP | 1.00% | March 24, 2025 | |
| October 5, 2023 | Marshall Wace LLP | 0.95% | March 24, 2025 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=12